← Leaderboards
Gale Lucas
Tamade, Llc
$404,857
Attributed
$1,214,571
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $989.6K · FY2019–22$1M$750K$500K$250K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,214,571 · 1
By mechanism
R44$1,214,571 · 1
Top collaborators
- Aman Mahajan2 shared
- Celine Tien2 shared
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectDisabilityAnxietyAuditoryAcute Pain ManagementBiofeedbackBiofeedback TrainingBiometryChronic DiseaseChronic Low Back PainAmericanBaseChronic Pain PatientClinicClinics And HospitalsCollaborationsCollectionComputersComputer SoftwareConsciousConsultDependenceChronic PainDistraction
Grant awards (2)
Opioid-Sparing pain management for Chronic Low Back Pain patients using TMC-CP01 - A VANISH (Virtual Autonomic Neuromodulation Induced Systemic Healing) based program$989,571
R44 · FY2022 · DA
Opioid-Sparing pain management for Chronic Low Back Pain patients using TMC-CP01 - A VANISH (Virtual Autonomic Neuromodulation Induced Systemic Healing) based program$225,000
R44 · FY2019 · DA